EUVIMEDEUVIMED entdecken
Crossref

Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study

Mari Wataya-Kaneda iD, Shinichirou Maeda iD, Ayumi Nakamura iD, Misa Hayashi iD, Manabu Fujimoto iD

The Journal of Dermatology · 2023

DOI: 10.1111/1346-8138.16930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Mari Wataya-Kaneda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: Vascular Malformations, Nevus, Blue, Skin Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Health and Labour Sciences Research Grant, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous clinical trials of sirolimus, an inhibitor of mechanistic/mammalian target of rapamycin complex 1, for the treatment of vascular malformations have been conducted. However, aside from lymphatic malformations, the efficacy of sirolimus for venous and capillary malformations has not been established. Moreover, no generalized venous or capillary malformations have been treated with topical sirolimus. To evaluate the safety and efficacy of topical sirolimus for venous and capillary malformations and to compare the efficacy of topical and systemic sirolimus therapy, an open‐label single‐arm pilot study with 0.2% sirolimus gel was conducted from July 19, 2019, to January 30, 2020, in four patients diagnosed with different vascular malformations (blue rubber bleb nevus syndrome, common venous malformation, phakomatosis pigmentovascularis type IVb, and angiokeratoma in Fabry disease). The primary endpoint was the safety evaluation of sirolimus gel. The main secondary endpoint was the improvement rate evaluated by the Central Judgment Committee at 12 weeks using photographs. No adverse events were observed. Blood sirolimus was not detected in any patient. Two patients (50%) had mild improvement, and the remaining two patients (50%) showed no change after 12 weeks of treatment. Blue rubber bleb nevus syndrome, a generalized venous malformation, showed the greatest response. In conclusion, 0.2% sirolimus gel was found to be as clinically effective as systemic sirolimus treatment in patients with venous and capillary malformations and more effective for early active lesions, even systemic venous malformations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular MalformationsNevus, BlueSkin NeoplasmsGastrointestinal NeoplasmsCapillariesPilot ProjectsHumansSirolimusImmunosuppressive Agents

Stichwörter der Autor:innen

Angiokeratoma in Fabry diseaseblue rubber bleb nevus syndrome (BRBNS)pilot studytopical sirolimus gelvascular malformations

Substanzen

SirolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Neurocutaneous Medicine, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Department of Pharmacy, Osaka University Hospital, Osaka, Japan.

ORCID-Profile: Mari Wataya-Kaneda, Shinichirou Maeda, Ayumi Nakamura, Misa Hayashi, Manabu Fujimoto

Förderung

  • Health and Labour Sciences Research Grant
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Wataya-Kaneda, M., Maeda, S., Nakamura, A., Hayashi, M., & Fujimoto, M. (2023). Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16930

Vancouver

Wataya-Kaneda M, Maeda S, Nakamura A, Hayashi M, Fujimoto M. Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16930

BibTeX
@article{WatayaKaneda2023,
  author = {Wataya-Kaneda, Mari and Maeda, Shinichirou and Nakamura, Ayumi and Hayashi, Misa and Fujimoto, Manabu},
  title = {Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study},
  journal = {The Journal of Dermatology},
  year = {2023},
  doi = {10.1111/1346-8138.16930}
}
Kostenlos starten →